Enzo Biochem Inc/ US2941001024 /
20/09/2024 22:10:00 | Chg. +0.04 | Volume | Bid22:29:14 | Ask22:29:14 | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
1.18USD | +3.51% | 54,161 Turnover: 59,123.87 |
1.11Bid Size: 1,000 | 1.14Ask Size: 200 | 60.72 mill.USD | - | 2.88 |
Fundamentals
FY 2023 | Growth (1Y) | |
---|---|---|
Per Share | ||
Earnings per Share: | 0.41 USD | - |
EPS Diluted: | 0.41 USD | - |
Revenues per Share: | 0.62 USD | -72.01% |
Book Value per Share: | 1.55 USD | 39.02% |
Cash Flow per Share: | -0.73 USD | 115.07% |
Dividend per Share: | - USD | - |
Total | in mill. | |
Revenues: | 31.06 USD | -70.99% |
Net Income: | 20.29 USD | - |
Operating Cash Flow: | -36.98 USD | - |
Cash and Cash Equivalents: | 82.37 USD | - |
Valuation Ratios
Current | Latest FY* | |
---|---|---|
P/E Ratio: | 2.88 | 3.61 |
P/S Ratio: | 1.92 | 2.41 |
P/BV ratio: | 0.76 | 0.95 |
P/CF Ratio: | -1.61 | -2.02 |
PEG: | - | - |
Earnings Yield: | 34.75% | 27.70% |
Dividend Yield: | - | - |
Market Capitalization | ||
Market Capitalization: | 60.72 mill. USD | 74.72 mill. USD |
Free Float Market Cap.: | - USD | - USD |
Market Cap. / Employee: | - USD | - USD |
Shares Outstanding: | 51.46 mill. |
Profitability
Gross Profit Margin: | 42.48% |
EBIT Margin: | -79.64% |
Net Profit Margin: | 65.32% |
Return on Equity: | 25.86% |
Return on Assets: | 16.65% |
Financial Strength
Liquidity I / Cash Ratio: | 205.99% |
Liquidity II / Quick Ratio: | 218.01% |
Liquidity III / Current Ratio: | 246.21% |
Debt / Equity Ratio: | 55.34% |
Dynam. Debt / Equity Ratio: | -117.42% |
Efficiency
Employees: | - |
Personal Expenses / Employee: | - USD |
Revenues / Employee: | - USD |
Net Income / Employee: | - USD |
Total Assets / Employee: | - USD |
* Fiscal Year End: | 31/07/2023 |
Accounting Standard: | US GAAP |
Currency: | USD |